JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Cessation of Ms Padmini Khare Kaicker as Non- Executive Independent Director of the company w.e.f. August 30, 2025.
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ms. Padmini Khare Kaicker (DIN: 00296388) has ceased to be a Non-Executive Independent Director of JB Chemicals & Pharmaceuticals Limited effective August 30, 2025, upon completion of her five-year term as an Independent Director. The company filed this disclosure with the stock exchange under SEBI Listing Regulations. No reason beyond the natural expiry of her term has been disclosed.
This is a routine, planned board change at the end of a fixed five-year tenure and is unlikely to materially affect the stock price or shareholder value. Investors may watch for the appointment of a replacement independent director to maintain board composition.